| Autor: |
Marti-Marti, Ignasi, Puig, Susana, Albero-González, Raquel, Masferrer, Emili, Iglesias, Pablo, Pérez-Anker, Javiera, Serra-García, Laura, Tarroch, Xavier, Curcó, Neus, Toll, Agustí |
| Předmět: |
|
| Zdroj: |
Clinical & Experimental Dermatology; Sep2024, Vol. 49 Issue 9, p1060-1062, 3p |
| Abstrakt: |
This article discusses a case of metastatic basal cell carcinoma (BCC) with neuroendocrine differentiation (BCCNE) and its response to the immunotherapy drug cemiplimab. BCC is a common type of cancer, but metastatic BCC is rare and has a high mortality rate. The patient in this case had an mBCC with neuroendocrine differentiation, which is a rare histological variant. Previous treatments did not work, but the patient responded well to cemiplimab, leading to complete remission of the cancer. The article suggests that cemiplimab could be a suitable therapeutic option for patients with metastatic BCCNE. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
